CanSino Biologics Inc (CASBF)
2.10
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
CanSino Biologics Shareholders Equity (Quarterly): 717.58M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 717.58M |
| December 31, 2023 | 744.10M |
| September 30, 2023 | 790.91M |
| June 30, 2023 | 815.09M |
| June 30, 2023 | 815.09M |
| December 31, 2022 | 978.08M |
| June 30, 2022 | 1.149B |
| June 30, 2022 | 1.149B |
| December 31, 2021 | 1.254B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.085B |
| June 30, 2021 | 1.085B |
| December 31, 2020 | 929.22M |
| June 30, 2020 | 194.20M |
| June 30, 2020 | 194.20M |
| December 31, 2019 | 210.17M |
| June 30, 2019 | 226.62M |
| June 30, 2019 | 226.62M |
| December 31, 2018 | 73.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
194.20M
Minimum
Jun 2020
1.254B
Maximum
Dec 2021
739.10M
Average
815.09M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.709B |
| CASI Pharmaceuticals Inc | 15.47M |
| Zai Lab Ltd | 762.17M |
| Gracell Biotechnologies Inc (DELISTED) | 222.18M |
| Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.204B |
| Total Liabilities (Quarterly) | 486.51M |
| Debt to Equity Ratio | 0.412 |
| Current Ratio | 2.389 |
| Net Debt Paydown Yield | 2.61% |